BioNTech SE (BNTX) Shares Outstanding (2018 - 2025)
BioNTech SE (BNTX) posted Shares Outstanding (Entity) of $4.4 billion for Q4 2025, up 0.54% sequentially from $4.3 billion in Q4 2024, and up 0.54% YoY from $4.3 billion in Q4 2024.
BioNTech SE (BNTX) Shares Outstanding (2018 - 2025) Analysis & Trends
BioNTech SE has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $4.4 billion in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 0.54% year-over-year to $4.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 billion (up 0.54% YoY) and the FY2025 annual result came in at $4.4 billion, up 0.54% from the prior year.
- Shares Outstanding (Entity) advanced to $4.4 billion in Q4 2025 per BNTX's latest filing, from $4.3 billion in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $4.4 billion in Q4 2021 and troughed at $4.3 billion in Q4 2024.
- A 5-year average of $4.4 billion and a median of $4.4 billion in 2025 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Entity) gained 3.63% in 2021, then fell 1.11% in 2023.
- Over 5 years, Shares Outstanding (Entity) stood at $4.4 billion in 2021, then fell by 0.29% to $4.4 billion in 2022, then declined by 1.11% to $4.3 billion in 2023, then declined by 0.08% to $4.3 billion in 2024, then increased by 0.54% to $4.4 billion in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $4.4 billion, $4.3 billion, and $4.3 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | Roivant Sciences | 26.52 Bn | 26.52 Bn | 1.16 Mn | 720.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 240.40 Mn |
| Sep 30, 2025 | 240.40 Mn |
| Jun 30, 2025 | 240.40 Mn |
| Mar 31, 2025 | 240.40 Mn |
| Dec 31, 2024 | 240.40 Mn |
| Sep 30, 2024 | 240.60 Mn |
| Jun 30, 2024 | 240.60 Mn |
| Mar 31, 2024 | 240.60 Mn |
| Dec 31, 2023 | 240.60 Mn |
| Sep 30, 2023 | 243.30 Mn |
| Jun 30, 2023 | 243.30 Mn |
| Mar 31, 2023 | 243.30 Mn |
| Dec 31, 2022 | 243.30 Mn |
| Sep 30, 2022 | 244.00 Mn |
| Jun 30, 2022 | 244.00 Mn |
| Mar 31, 2022 | 244.00 Mn |
| Dec 31, 2021 | 244.00 Mn |
| Sep 30, 2021 | 235.44 Mn |
| Jun 30, 2021 | 235.44 Mn |
| Mar 31, 2021 | 235.44 Mn |